GlassScriptPhysician profile
Linda Mosby
NPI 1578559605
$4,916.19
in general payments reported to CMS, 2019-2025
16 companies · $978 in 2025
The $978 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,029 · 2022: $1,222 · 2023: $985 · 2024: $703 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,665.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,328.56 | 2021-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $971.33 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $544.96 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $541.29 | 2021-2025 | |
| Glaxosmithkline, LLC. | $492.86 | 2021-2025 | Trelegy Ellipta, Penmenvy, Shingrix |
| Daiichi Sankyo INC. | $276.87 | 2021-2023 | Injectafer |
| C2n Diagnostics, LLC | $170.35 | 2025 | Precivityad2 |
| Kowa Pharmaceuticals America, INC. | $151.73 | 2025 | Zoryve |
| Beta Bionics, INC. | $107.43 | 2024 | Ilet Bionic Pancreas |
| Dexcom, INC. | $100.59 | 2024-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Dynavax Technologies Corporation | $98.04 | 2024-2025 | Heplisav-B |
| Pfizer INC. | $45.19 | 2024-2025 | |
| Exact Sciences Corporation | $31.29 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Shield Therapeutics INC | $27.27 | 2023 | Accrufer |
| Masimo Corporation | $14.87 | 2024 | Set and Rainbow Set |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Mosby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.